Sirion Therapeutics (drug rights)

Business Data, Corporate Office and Headquarter Address

About

Sirion Therapeutics (drug rights) is Buildings and Property in United States that focus on United States rights business. They cover business area such as United States right, durezol, emulsion, global right, ZYCLORIN, postoperative inflammation, pain, ocular surgery, immunosuppressive agent.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

United States Rights

Website

-

Corporate Office and Headquarter Office address:

3110 Cherry Palm Drive
Suite 340
Tampa, FL 33619
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

United States rightdurezolemulsionglobal rightZYCLORINpostoperative inflammationpainocular surgeryimmunosuppressive agent

* We use standard office opening hours in near Sirion Therapeutics (drug rights)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Sirion Therapeutics (drug rights) Frequently Asked Questions

What or who is Sirion Therapeutics (drug rights)?

Sirion Therapeutics (drug Rights) is Buildings and Property business from United States that founded in - ( years old in ), Sirion Therapeutics (drug rights) business is focusing on United States Rights.

Where is Sirion Therapeutics (drug rights) headquarter and corporate office address?

Sirion Therapeutics (drug rights) headquarter office and corporate office address is located in 3110 Cherry Palm Drive Suite 340 Tampa, FL 33619 United States.

Where is Sirion Therapeutics (drug rights) country origins?

Sirion Therapeutics (drug rights) was founded in United States.

What is United States Rights business focus on?

In , Sirion Therapeutics (drug rights) is currently focus on United States rights sector.

Disclaimer: This website is not affiliated with Sirion Therapeutics (drug rights), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.